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Dioxin-like polychlorinated biphenyls (DL-PCBs) are environmental pollutants that have been 22 
associated with impaired semen quality. However, research on the potential impact of paternal 23 
exposure to DL-PCBs and the risk of adverse pregnancy outcomes are limited. We examine the 24 
relationship between serum DL-PCB concentrations and IVF outcomes among 42 males seeking 25 
fertility treatment. Concentrations of 12 serum DL-PCBs were analyzed by high-resolution gas 26 
chromatography coupled to high-resolution mass spectrometry. Modified Poisson regressions, 27 
adjusted for confounders, were used to assess bivariate associations and to estimate risk ratios (RRs) 28 
between DL-PCBs and binary IVF outcomes. The median concentration (25th-75th percentiles) of 29 
the sum of the 12 DL-PCBs (∑DL-PCBs) obtained for the patients was 5.42 (3.78-7.78) ng/g lipid. 30 
No statistically significant association between DL-PCB levels and embryo quality was found. 31 
However, men with high serum PCB-77 concentrations present more probability of high-quality 32 
embryos (RR: 0.292; 95% CI: 0.090-0.942), whereas the opposite trend is observed for men with 33 
lower serum levels of PCB-156 (RR: 7.960; 95% CI: 1.020-62.100), who present increased odds of 34 
high-quality embryos. Serum concentrations of PCB-126 and PCB-114 were associated with 35 
decreased implantation rates (p<0.05). Moreover, PCB-77 and ∑non-ortho PCBs were significantly 36 
associated with a lower likelihood of clinical pregnancy (p<0.05). A lower likelihood of live birth 37 
was associated with higher levels of PCB-77, PCB-105, PCB-118, and recording significant 38 
differences for ∑non-ortho PCBs, ∑mono-ortho PCBs, and ∑DL-PCBs (p<0.05). 39 
These findings suggest that paternal DL-PCB exposure before conception may be related to 40 
pregnancy endpoints. However, DL-PCB measurement were limited to male partners. Therefore, 41 
we propose that future studies with larger population sizes should include both maternal and paternal 42 
factors. 43 
Keywords: dioxin-like polychlorinated biphenyls, IVF, embryo quality, implantation, clinical 44 






















1. Introduction  47 
Environmental pollutants exert adverse physiological effects on testicular function and male fertility 48 
(Swan, 2006). Among others, highly toxic persistent organic pollutants including dioxin-like 49 
compounds such as dioxin-like polychlorinated biphenyls (DL-PCBs) negatively impact the human 50 
reproductive system (Leijs et al., 2014). Although emissions of these compounds have decreased 51 
during recent years, the general population is still exposed to detectable levels (Costopoulou et al., 52 
2006; Zubero et al., 2011; De Felip et al., 2014; Domingo et al., 2017; Brajenović et al., 2018). 53 
Similar to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), one of the most toxic pollutants known, 54 
DL-PCBs bind to the aryl hydrocarbon receptor (AhR) (van den Berg et al., 2006), showing a 55 
decrease in sperm quality and sperm DNA integrity (Meeker and Hauser, 2010). Further, they are 56 
identified as endocrine-disrupting compounds (EDCs), disrupting hormonal functions, especially 57 
during early development and pregnancy (Mitro et al., 2015). 58 
Early reports show evidence on the association between dioxin/PCB exposure and semen quality 59 
(Guo et al., 2000; Hsu et al., 2003; Dhooge et al., 2006; Toft et al., 2007; Mocarelli et al., 2011; 60 
Mínguez-Alarcón et al., 2016). However, the potential impact of paternal exposure to environmental 61 
chemicals in general, and dioxin-like compounds in particular, and the risk of adverse pregnancy 62 
effects have been currently only delineated (Cordier, 2008). Instead, reports on mice for example, 63 
accurately demonstrated that adult males exposed in utero to TCDD displayed diminished fertility 64 
and an increased risk of spontaneous preterm birth when compared to their unexposed mating 65 
partners (Ding et al., 2011; McConaha et al., 2011; Bruner-Tran et al. 2014). 66 
Other studies have shown that utero/developmental TCDD exposure in rats, decreases sperm quality 67 
in all adult male rat offspring (F1, F2, F3 generations) at least at one dose, and this effect persists 68 
into the next generations (Sanabria et al., 2016). Other reports show that DL-PCB congeners 77 and 69 
126 decreased serum testosterone concentrations in adult male rats exposed in utero (Faqui et al., 70 











individual PCB-77 was associated with impairment of sperm functions and fertilization ability in 72 
mature rats. Furthermore, there is epidemiological evidence for potentially adverse outcomes after 73 
paternal exposure to DL-PCBs. For instance, epidemiological studies have associated the effects of 74 
dioxin or DL-PCB exposure and adverse effects on pregnancy outcomes, such as miscarriages 75 
(Donovan et al., 1984), altered sex ratio of children (Ryan et al., 2002) and congenital malformations 76 
(Dimich-Ward et al., 1996; Ngo et al., 2010). Additionally, Buck Louis et al. (2013) showed that 77 
male exposure to DL-PCBs, such as non-ortho PCBs 156 and 157, are associated with a longer 78 
time-to-pregnancy (TTP) and an increased risk of infertility.  79 
Currently, clinical evidence derived from the use of assisted reproductive technology (ART) 80 
supports the crucial contribution of the male gamete during early embryo development (Barroso et 81 
al., 2009; Stuppia et al., 2015). Recently we reported that serum DL-PCB concentrations largely 82 
affect semen quality among males seeking fertility treatments (Paul et al., 2017). Based on our 83 
earlier results, here we hypothesized that greater paternal serum DL-PCB levels would be associated 84 
with poorer embryo quality and a lower likelihood of pregnancy and live birth. Therefore, studying 85 
couples undergoing in vitro fertilization (IVF) provides us with the opportunity to explore the impact 86 
of paternal preconception serum concentrations of DL-PCBs on pregnancy endpoints.  87 
2. Materials and methods 88 
2.1. Study design and subject selection 89 
The current study was conducted as part of a cross-sectional study on DL-PCB exposure and semen 90 
quality (see Paul et al., 2017 for details). The original population included 56 couples seeking IVF 91 
treatment between May 2012 and June 2014 at the IVF Spain clinic (Alicante, Spain), whose males 92 
(30-55 age range) had DL-PCB measurements in serum. Patients with known factors related to male 93 
infertility such as varicocele, post-vasectomy or cryptorchidism, endocrine hypogonadism 94 










karyotype or Y chromosome microdeletions were excluded from the study (6 out of 56 subjects, 96 
resulting in a final n = 50).  97 
Since the present study assesses the influence of paternal DL-PCB exposure on embryo 98 
development, the following inclusion criteria were subsequently applied to the cohort:  99 
● Couples whose males had DL-PCB measurements. 100 
● Couples who underwent only one fresh IVF cycle. 101 
● Young female partners (<37 years old). 102 
● Women not affected by known infertility factors such as polycystic ovarian syndrome 103 
(PCOS), endometriosis or showing diminished ovarian reserve or low response to ovarian 104 
stimulation.  105 
● Female patients treated with ovarian follicle stimulation using short GnRH antagonist 106 
protocol. 107 
● Couples with body mass index (BMI) <30 kg/m2. 108 
● Only non-smokers.  109 
● Couples not using donor oocytes or sperm. 110 
The criteria reported above were applied in order to avoid bias with factors that might affect IVF 111 
outcomes (van Loendersloot et al., 2010; Ferraretti et al., 2011; Stimpfel et al., 2015; Lucovnik et 112 
al., 2018).  113 
Figure 1 shows the flow chart of inclusion and drop out of patients included in the study. Among 114 
56 eligible patients asked to participate, 14 couples were ultimately excluded. Hence, the study 115 













Figure 1. Flow chart of inclusion and drop-out of patients. 119 
A complete clinical examination was performed on every patient, and a questionnaire was used to 120 
collect individual information, including relevant data on demographics, medical history, lifestyle 121 
factors and questions about potential occupational exposures to environmental chemical 122 
compounds. All participants provided informed consent after a research nurse explained the study 123 
procedures and all questions were answered. A written consent form of each subject was taken after 124 
explaining the aims and objectives of the study and its benefits to individuals and society. The 125 
Male Infertility Factors  
6 exclusions: 
2 varicocele 
2 Y chromosome microdeletions 
1 cryptorchidism  
1 immune infertility 
Analyzed n=50 
Couples who males had PCB measurements and 
the first fresh IVF cycle 
Included n=42 
Couples finally included in the present study 
8 exclusions: 
2 donor oocytes 
1 female partner >37 years old 
2 BMI >30 kg/m
2
 
2 smokers  
1 frozen IVF cycle 
Clinical pregnancy n=22 
Live birth n=15 
Implantation n=23 
Eligible patients n=56 
 Male partners of couples seeking infertility 
treatment. 
Number of embryos transferred 
  3 patients without embryo transfer 
13 patients had 1 embryo transferred 
25 patients had 2 embryos transferred 











Human Research Committee of the University General Hospital of Alicante (Spain) approved this 126 
study, in accordance with the principles of the Declaration of Helsinki. 127 
2.2. Clinical procedures 128 
Couples were selected at their first IVF treatment cycle (conventional in vitro fertilization, IVF; or 129 
Intracytoplasmic sperm injection, ICSI). Trained research nurses obtained all IVF outcome variables 130 
from the medical record. Each couple contributed only one treatment cycle to the study. To avoid 131 
potential confounding by treatment protocol, all female patients were treated with ovarian follicle 132 
stimulation using short GnRH antagonist protocol with rFSH/hMG after completing a cycle of oral 133 
contraceptives. 134 
Recombinant FSH (Gonal-F) followed by hMG (Menopur) was used starting on cycle day 3 of the 135 
menstrual cycle. When the lead follicle reached 14 mm in diameter, 0.25 mg cetrorelix (Cetrotide; 136 
Serono) were added until the day of hCG (Ovitrelle) administration. Serum estradiol measurements 137 
and transvaginal ultrasonography were employed to monitor follicular maturation and endometrial 138 
development. 139 
Ovarian stimulation was induced with 10000 IU of serum beta-human chorionic gonadotropin 140 
(β-hCG), when at least three dominant follicles ≥ 17 mm diameter were noted and peak estradiol 141 
level was higher than 600 pg/mL. Oocyte retrieval was performed approximately 36 hours. 142 
The endpoints assessed included intermediate IVF outcomes (embryo quality) and clinical IVF 143 
outcomes (implantation, clinical pregnancy and live birth) based on previous reports (ESHRE 144 
Special Interest Group of Embryology and Alpha Scientists in Reproductive Medicine, 2017). 145 
Embryo quality 146 
Embryo quality was described using criteria based on blastomeres size and number, the degree of 147 
fragmentation, and the presence of multinucleated blastomeres. We dichotomized embryo quality 148 
as high-quality versus low-quality embryo. Embryos with an absence of multinucleated blastomeres, 149 











were regarded as high-quality embryos (Van Royen et al., 1999). Embryos were transferred on the 151 
second or third day after fertilization. In 3 cases, embryos were not transferred due to impaired 152 
quality. 153 
Implantation 154 
Determination of serum β-hCG is an important tool for the diagnosis of implantation outcome of in 155 
vitro fertilization cycles (Bjercke et al., 1999). Implantation was defined as β-hCG level > 5 156 
mIU/mL, typically measured 17 days after embryo transfer. When levels did not reach 5 mIU/mL, 157 
implantations were considered negative (failure of implantation).  158 
Clinical pregnancy  159 
The presence of a gestational sac on ultrasound and a fetal heartbeat at 7 weeks amenorrhea was 160 
considered a clinical pregnancy.  161 
Live birth 162 
Live birth was defined as an infant born alive after 24 weeks’ gestation.  163 
2.3. Serum DL-PCB analysis 164 
Serum samples were collected from male partners on the same day as semen samples obtained, 165 
based on Paul et al. (2017), before the day of oocyte retrieval. Samples were immediately stored in 166 
the dark at –20 ºC until DL-PCB analysis. We determined 12 coplanar DL-PCB congeners, 167 
comprising 4 non-ortho-substituted PCBs (77, 81, 126 and 169) and 8 mono-ortho-substituted PCBs 168 
(105, 114, 118, 123, 156, 157, 167 and 189), using a recently developed method for the analysis of 169 
DL-PCBs in serum (Moltó et al., 2016). Serum samples were analyzed using high-resolution gas 170 
chromatography coupled with high-resolution mass spectrometry (HRGC-HRMS).  171 
Based on our previous study (Paul et al., 2017), non-detects, i.e. congeners with values below the 172 
limit of detection (LOD), were assigned a value equal to the LOD, and only those congeners with 173 
at least 60% of the values above the LOD were included in further analysis, following the same 174 











met this requirement (Table S1), so all of them were considered for further evaluation. 176 
Concentrations of PCBs were adjusted for total serum lipids. DL-PCB concentrations are reported 177 
both individually and as the sum of all congeners assayed (∑DL-PCBs) and expressed in nanograms 178 
of compound per gram of total lipids (ng/g lipid). Serum total cholesterol and triglycerides were 179 
measured enzymatically, and total lipids concentrations calculated by Phillips formula (Phillips et 180 
al., 1989; Bernert et al., 2007). 181 
Because of financial constraints and the complexity of the analysis, it was not possible to measure 182 
PCBs in serum from female partners in the study. 183 
2.4. Statistical analyses 184 
We explored the relationship between IVF outcomes and DL-PCB congeners. Age (years) and body 185 
mass index (BMI; kg/m2) were considered in both the male patient and his female partner (Sharma 186 
et al., 2013) (Table 1). We followed statistical methods previously outlined (Bloom et al., 2017; 187 
Dodge et al., 2020). The Shapiro-Wilk test was first performed in order to test the distribution and 188 
equal variance in DL-PCB values, showing that 86.6% of the PCBs were not normally distributed 189 
(W = 0.49 to 0.93; p<0.05). In order to discard a possible selection bias, the non-parametric Mann–190 
Whitney U test was used to compare DL-PCB concentrations, seminal and demographic (age and 191 
BMI) parameters between couples included in our analyses and patients excluded (see Figure 1) 192 
showing non-significant differences. We then used modified Poisson regression models (Zou, 193 
2004), which combine a log Poisson regression model with robust variance estimation, to estimate 194 
the Relative Risk (RR) and corresponding 95% confidence interval (CI) between log-transformed 195 
DL-PCB concentrations and dichotomous IVF outcomes, which included embryo quality (modeled 196 
as the proportion of high/low quality embryos), the successes of embryo implantation, clinical 197 
pregnancy and live birth,  with adjustment for age, BMI and serum lipids confounders. We choose 198 
a modified Poisson regression approach due to our modeling of dichotomous outcomes and to 199 











is generally the preferred measure of association for clinical purposes (Dodge et al., 2020; Gallis et 201 
al., 2019). Finally, correlations between serum DL-PCB concentrations were assessed using 202 
Spearman () correlation coefficients. Descriptive and statistical analyses were performed using 203 
IBM® SPSS® Statistics 22.0 (IBM, Armonk, NY, USA) and Jamovi 1.2.27. Results are presented 204 
as median and 25th-75th percentiles for each DL-PCB congener. Two-sided p-values <0.05 were 205 
considered to be statistically significant.  206 
3. Results 207 
3.1. Characteristics of patients 208 
The demographic characteristics and infertility diagnoses are shown in Table 1. At the time of the 209 
procedure, subjects’ age (years) was 38.53 ± 5.11 for males and 32.97 ± 2.10 for females, 210 
respectively. Regarding body weight, mean BMI (kg/m2) for males and females were 24.50 ± 2.46 211 
and 23.13 ± 1.78, respectively, being 76.19% of males and 85.71% of females classified as normal 212 
in weight (18.5 ≤ BMI ≤ 24.9, in kg/m²). Most couples had no previous IVF attempts (71%) and all 213 
participants were white and nonsmokers. Regarding infertility diagnoses among couples, in 48% of 214 
them a male factor infertility was diagnosed, 31% presented tubal factor infertility (female 215 
infertility), and 21% had unexplained infertility. 216 
Table 1. Characteristics of demographic factors and infertility diagnoses among 42 participating 217 
couples. 218 
Characteristics N (%) Mean σ Median Min-Max 
Age (years)      
Male - 38.53 5.11 39 30-46 
Female - 32.97 2.10 33 28-37 
BMI (kg/m2)      
Male  - 24.50 2.46 24.18 17.97-31.25 
Female - 23.13 1.78 23.12 19.37-26.25 
Smoker      
Male nonsmoker (yes) 42 (100%) - - - - 
Female nonsmoker (yes) 42 (100%) - - - - 











Male 42 (100%) - - - - 
Female 42 (100%) - - - - 
Infertility diagnoses      
Male factor alone 20 (48%) - - - - 
Female factor alone 13 (31%) - - - - 
Unexplained 9 (21%) - - - - 
Data are presented as N (%) or mean. 
σ = standard deviation. 
Min-Max = minimum and maximum values. 
BMI = body mass index. 
 
Semen parameters and IVF outcomes are reported in Table 1. From the 42 couples selected for the 219 
study, 27 underwent ICSI treatment, whereas 15 were subjected to a conventional IVF. A total of 220 
631 oocytes were retrieved, yielding an average (mean ± standard deviation, per couple) of 221 
15.03±5.46 oocytes per couple, 605 (14.40±5.42) were mature (MII) and 430 (10.23±3.98) of them 222 
were fertilized. Three days later, embryos were assessed for embryo quality, of which 211 223 
(5.03±0.22) were classified as high quality. The majority of embryos (64%) were transferred on day 224 
3. There were 23 (55%) positive embryo implantations, 22 (52%) clinical pregnancies and 15 (36%) 225 
live births. 226 
Table 2. Semen parameters and IVF outcomes among 42 participating couples. 227 
Semen Parameters N (%) Mean σ Median Min-Max 
Semen volume (mL) 42 (100%) 2.74 1.27 2.80 0.30-5.00 
Sperm concentration (x106/mL) 42 (100%) 45.07 50.77 32.00 1.30-180.00 
Sperm progressive motility (%) 42 (100%) 48.40 30.39 60.00 2.00-90.00 
Sperm viability (%) 42 (100%) 75.52 20.81 85.00 15.00-95.00 
Normal morphology (%) 42 (100%) 9.96 5.92 10.00 1.00-23.00 
IVF/ICSI attempts      
0 30 (71.4%) - - - - 
1 4 (9.5%) - - - - 
≥2 8 (19%) - - - - 
Day 3 FSH (IU/L) - 6.73 1.72 6.50 3.00-13.00 
Day 3 Estradiol (pg/mL) - 2148 1213 2069 285-6259 
Endometrial thickness (mm) - 10.20 1.80 9.70 5.00-12.00 











Retrieved oocytes 631 (100%) 15.03 5.46 15.00 1.00-31.00 
Mature oocytes MII 605 (96%) 14.40 5.42 14.00 1.00-31.00 
2PN-zygotes a 430 (68%) 10.23 3.98 10.00 1.00-20.00 
Fertilization rate (%)b - 74.08 18.33 72.77 26.08-100 
High quality embryos at day 3c 211 (33%) 5.03 0.22 0.48 0.09-1.00 
Day of embryo transfer      
2 15 (35.7%) - - - - 
3 27 (64.3%) - - - - 
Number of embryos transferred      
0 3 (7.14%) - - - - 
1 13 (30.95%) - - - - 
2 25 (52.52%) - - - - 
3 1 (2.4%) - - - - 
Implantation 23 (55%) - - - - 
Clinical pregnancy 22 (52%) - - - - 
Live birth 15 (36%) - - - - 
Data are presented as N (%) or mean. σ = standard deviation. Min-Max = minimum and maximum values. 228 
IVF = in vitro fertilization. ICSI = Intracytoplasmic sperm injection. 229 
FSH = follicle stimulating hormone.  230 
a Number of zygotes with 2 pronuclei. b Number of zygotes with 2 pronuclei / number of mature metaphase II 231 
oocytes. cVan Royen et al., 1999. 232 
Implantation = β-hCG level > 5 mIU/mL 17 days after embryo transfer. 233 
Clinical pregnancy = presence of a gestational sac on ultrasound and a fetal heartbeat at 7 weeks amenorrhea. 234 
  Live birth = an infant born alive after 24 weeks of gestation. 235 









3.1. Levels of DL-PCBs in serum 237 
Descriptive statistics of the concentrations of DL-PCBs expressed as ng/g lipid in the serum samples 238 
are summarized in Table . The total levels of DL-PCBs (∑DL-PCBs) obtained for the patients ranged 239 
from 2.02 to 13.23 ng/g lipid, with a median value of 5.42 ng/g lipid. The predominant congeners, 240 
in descending order, were PCBs 118, 156, and 105, with median values of 2.13, 0.87, and 0.45 ng/g 241 
lipid, respectively. 242 
Table 3. Levels of DL-PCBs (ng/g lipid) in serum samples (n = 42). 243 
Congeners Mean SD Min Max Median 25th 75th 
Non-ortho PCBs    
PCB-77 0.35 0.45 0.02 1.44 0.15 0.08 0.38 
PCB-81 0.06 0.03 0.01 0.13 0.05 0.04 0.07 
PCB-126 0.13 0.11 0.03 0.53 0.09 0.06 0.18 
PCB-169 0.18 0.19 0.06 1.01 0.11 0.08 0.27 
Mono-ortho PCBs    
PCB-105 0.62 0.46 0.14 1.96 0.45 0.30 0.88 
PCB-114 0.15 0.15 0.03 0.78 0.12 0.05 0.19 
PCB-118 2.23 1.29 0.21 5.22 2.13 1.36 3.09 
PCB-123 0.21 0.33 0.02 1.75 0.09 0.06 0.24 
PCB-156 1.02 0.64 0.20 2.63 0.87 0.57 1.32 
PCB-157 0.25 0.18 0.07 0.82 0.18 0.11 0.35 
PCB-167 0.27 0.19 0.07 0.79 0.22 0.13 0.40 
PCB-189 0.37 0.30 0.09 1.69 0.28 0.17 0.42 
∑DL-PCBs 5.80 2.85 2.02 13.23 5.42 3.78 7.78 
 244 
Correlations between individual PCBs 245 
Considering that PCBs are found as mixtures and tend to be highly intercorrelated, Spearman () 246 
correlation coefficients were used to assess relationships between PCB congeners (Table S2). We 247 
decided to focus on those congeners associated with IVF outcomes in the present work, i.e., PCB-248 
77, 105, 114, 118, 126 and 189. 249 
Non-ortho PCB-77 is highly correlated with ∑non-ortho PCBs (=0.747; p<0.001). In addition, 250 











105, presented strong correlations with PCB-118, ∑non-ortho PCBs, ∑mono-ortho PCBs and ∑DL-252 
PCBs (ρ=0.607–0.902; p<0.001), being also significantly correlated with PCB-123 (ρ=0.633; 253 
p<0.01). With respect to PCB-114, we found a significant correlation between this congener and 254 
PCB-118, ∑mono-ortho and ∑DL-PCBs (ρ=0.472-0.554; p<0.01). PCB-118 was highly correlated 255 
with ∑mono-ortho PCBs and ∑DL-PCBs (ρ=0.942–0.949; p<0.001). Furthermore, high 256 
correlations were observed between PCB-118 and PCB-123 (ρ=0.551; p<0.01) and 156 (ρ=0.504; 257 
p<0.01). In addition, a strong correlation was observed between PCBs 126 and 169 (ρ=0.519; 258 
p<0.01). Finally, PCB-189 showed a high correlation with PCB-156 (ρ=0.491; p<0.01). 259 
3.2. Paternal serum concentrations and IVF outcomes 260 
Embryo quality 261 
According to modified Poisson regression models adjusted for confounders (age, BMI and lipid 262 
serum), no statistically significant association between DL-PCB levels and embryo quality was 263 
found (Table 4). However, when looking at the risk ratios (RRs), it is interesting to notice that men 264 
with high serum PCB-77 concentrations present more probability of high-quality embryos (RR: 265 
0.292; 95% CI: 0.090-0.942), whereas the opposite trend is observed for men with lower serum 266 
levels of PCB-156 (RR: 7.960; 95% CI: 1.020-62.100), who present increased odds of high-quality 267 
embryos. 268 
Table 4. Embryo quality and serum DL-PCB concentrations (ng/g lipid) among male partners. 269 
 Low  High    
DL-PCBs Median 25th 75th  Median 25th 75th  RR (95% CI) p 
PCB-77 0.09 0.08 0.16  0.17 0.12 0.56  0.292 (0.090-0.942) 0.128 
PCB-81 0.06 0.04 0.07  0.05 0.04 0.08  0.287 (0.031-2.590) 0.370 
PCB-126 0.16 0.09 0.20  0.07 0.05 0.10  3.320 (0.466-23.700) 0.219 
PCB-169 0.13 0.08 0.27  0.11 0.07 0.27  1.260 (0.186-8.520) 0.833 
PCB-105 0.39 0.19 0.54  0.57 0.30 0.98  0.323 (0.054-1.910) 0.290 
PCB-114 0.11 0.07 0.20  0.12 0.05 0.19  1.150 (0.238-5.540) 0.885 
PCB-118 2.13 0.69 2.52  2.24 1.40 3.18  0.330 (0.076-1.420) 0.235 











PCB-156 1.11 0.89 1.51  0.76 0.47 1.21  7.960 (1.020-62.100) 0.134 
PCB-157 0.17 0.08 0.25  0.19 0.11 0.41  0.306 (0.034-2.740) 0.342 
PCB-167 0.26 0.18 0.47  0.20 0.13 0.38  3.150 (0.516-19.200) 0.308 
PCB-189 0.44 0.23 0.51  0.25 0.16 0.37  5.950 (0.843-42.100) 0.121 
∑non-ortho 0.55 0.39 0.62  0.61 0.34 1.02  0.347 (0.063-1.900) 0.404 
∑mono-ortho 4.91 2.86 5.16  4.84 3.38 7.29  0.580 (0.035-9.530) 0.723 
∑DL-PCBs 5.42 3.45 5.59  5.42 3.86 8.29  0.440 (0.025-7.590) 0.607 
Significant Relative Risk (RR) at p<0.05 in bold typeface. 
 270 
Implantation 271 
Association between implantation outcomes and male serum concentrations of DL-PCBs (Table 5) 272 
showed that the likelihood for embryo implantation was significantly lower for men with high serum 273 
concentrations of PCB-126 (RR: 0.351; 95% CI: 0.156-0.791; p=0.044) and PCB-114 (RR: 0.259; 274 
95% CI: 0.099-0.673; p=0.013). Even without a statistical significance at p<0.05, it can be observed 275 
that high serum levels of PCB-105 (RR: 0.406; 95% CI: 0.167-0.989), ∑non-ortho PCBs (RR: 276 
0.330; 95% CI: 0.114-0.952) and ∑DL-PCBs (RR: 0.261; 95% CI: 0.077-0.875) are associated with 277 
lower chances of implantation success. 278 
Table 5. Implantation outcomes and serum DL-PCB concentrations (ng/g lipid) among male 279 
partners. 280 
 Implantation failure  Implantation    
DL-PCBs Median 25th 75th  Median 25th 75th  RR (95% CI) p 
PCB-77 0.27 0.14 0.56  0.12 0.07 0.23  0.540 (0.279-1.050) 0.075 
PCB-81 0.05 0.03 0.10  0.06 0.05 0.07  1.480 (0.343-6.350) 0.560 
PCB-126 0.09 0.07 0.30  0.07 0.04 0.12  0.351 (0.156-0.791) 0.044 
PCB-169 0.12 0.08 0.28  0.11 0.07 0.26  0.619 (0.215-1.780) 0.381 
PCB-105 0.67 0.42 1.02  0.34 0.26 0.79  0.406 (0.167-0.989) 0.067 
PCB-114 0.16 0.12 0.29  0.07 0.04 0.13  0.259 (0.099-0.673) 0.013 
PCB-118 2.19 1.63 3.62  1.70 1.16 2.69  0.528 (0.277-1.010) 0.163 
PCB-123 0.12 0.06 0.26  0.09 0.06 0.22  0.893 (0.417-1.910) 0.766 











PCB-157 0.21 0.11 0.39  0.17 0.10 0.30  0.776 (0.277-2.180) 0.628 
PCB-167 0.19 0.13 0.50  0.24 0.13 0.33  1.050 (0.372-2.980) 0.918 
PCB-189 0.33 0.17 0.51  0.26 0.17 0.39  0.563 (0.194-1.630) 0.320 
∑non-ortho 0.65 0.48 1.54  0.44 0.31 0.66  0.330 (0.114-0.952) 0.065 
∑mono-ortho 5.75 3.54 8.06  4.54 2.70 5.19  0.307 (0.092-1.020) 0.100 
∑DL-PCBs 6.40 4.01 9.61  4.91 3.34 5.93  0.261 (0.077-0.875) 0.074 
Significant Relative Risk (RR) at p<0.05 in bold typeface. 
 281 
Clinical pregnancy  282 
With respect to clinical pregnancy (Table ), we found a significant association between lower 283 
likelihood of clinical pregnancy and higher levels of PCB-77 (RR: 0.275; 95% CI: 0.102-0.744; 284 
p=0.022) and the sum of non-ortho PCBs (RR: 0.129; 95% CI: 0.023-0.715; p=0.029). 285 
Table 6. Clinical pregnancy outcomes and serum DL-PCB concentrations (ng/g lipid) among male 286 
partners. 287 
 No Clinical pregnancy  Clinical pregnancy    
DL-PCBs Median 25th 75th  Median 25th 75th  RR (95% CI) p 
PCB-77 0.28 0.14 0.56  0.09 0.06 0.17  0.275 (0.102-0.744) 0.022 
PCB-81 0.05 0.04 0.09  0.05 0.05 0.07  0.788 (0.142-4.370) 0.793 
PCB-126 0.09 0.04 0.17  0.08 0.06 0.19  0.955 (0.292-3.120) 0.942 
PCB-169 0.12 0.08 0.28  0.11 0.07 0.21  0.516 (0.123-2.170) 0.400 
PCB-105 0.71 0.35 0.91  0.36 0.23 0.71  0.327 (0.087-1.220) 0.103 
PCB-114 0.12 0.05 0.20  0.11 0.05 0.19  0.678 (0.202-2.270) 0.533 
PCB-118 2.24 1.53 3.14  1.65 0.85 2.93  0.423 (0.174-1.020) 0.165 
PCB-123 0.12 0.06 0.28  0.07 0.05 0.17  0.403 (0.142-1.140) 0.152 
PCB-156 0.79 0.51 1.43  0.90 0.59 1.16  1.260 (0.286-5.560) 0.773 
PCB-157 0.17 0.11 0.30  0.19 0.11 0.44  1.390 (0.347-5.540) 0.646 
PCB-167 0.20 0.13 0.39  0.26 0.15 0.42  1.600 (0.424-6.030) 0.507 
PCB-189 0.29 0.18 0.51  0.25 0.16 0.40  0.579 (0.137-2.440) 0.494 
∑non-ortho 0.65 0.50 1.28  0.36 0.30 0.59  0.129 (0.023-0.715) 0.029 
∑mono-ortho 4.91 3.61 7.51  3.51 2.54 6.29  0.265 (0.042-1.660) 0.180 
∑DL-PCBs 5.59 4.30 7.95  4.01 2.99 7.42  0.193 (0.029-1.280) 0.115 












Live birth 289 
We found statistically significant associations after adjustment for confounders, between high levels 290 
of ∑DL-PCBs (RR: 0.046; 95% CI: 0.004-0.431; p=0.028) and a lower likelihood of live birth, also 291 
recording significant differences for ∑non-ortho PCBs (RR: 0.041; 95% CI: 0.008-0.192; p=0.017) 292 
and ∑mono-ortho PCBs (RR: 0.073; 95% CI: 0.008-0.674; p=0.045). By individual congeners, non-293 
ortho PCB-77 (RR: 0.099; 95% CI: 0.038-0.256; p=0.013), PCB-105 (RR: 0.107; 95% CI: 0.024-294 
0.475; p=0.019), and PCB-118 (RR: 0.225; 95% CI: 0.088-0.572; p=0.046) were associated with 295 
lower odds of live birth. Although not statistically significant, PBC-114 (RR: 0.192; 95% CI: 0.045-296 
0.822) and PCB-123 (RR: 0.203; 95% CI: 0.063-0.652) were also associated with lower chances of 297 
live birth.  298 
Table 7. Live birth outcomes and serum DL-PCB concentrations (ng/g lipid) among male partners. 299 
 No Live birth  Live birth    
DL-PCBs Median 25th 75th  Median 25th 75th  RR (95% CI) p 
PCB-77 0.27 0.14 0.56  0.07 0.05 0.10  0.099 (0.038-0.256) 0.013 
PCB-81 0.05 0.04 0.10  0.06 0.05 0.07  0.587 (0.092-3.740) 0.631 
PCB-126 0.09 0.05 0.18  0.09 0.06 0.18  0.833 (0.204-3.400) 0.817 
PCB-169 0.11 0.08 0.27  0.11 0.06 0.26  0.567 (0.094-3.420) 0.552 
PCB-105 0.74 0.37 1.02  0.31 0.17 0.37  0.107 (0.024-0.475) 0.019 
PCB-114 0.15 0.06 0.25  0.07 0.04 0.13  0.192 (0.045-0.822) 0.063 
PCB-118 2.34 1.61 3.21  1.55 0.60 2.56  0.225 (0.088-0.572) 0.046 
PCB-123 0.14 0.06 0.29  0.07 0.06 0.13  0.203 (0.063-0.652) 0.073 
PCB-156 0.89 0.55 1.47  0.77 0.55 1.13  0.771 (0.128-4.640) 0.792 
PCB-157 0.18 0.12 0.39  0.17 0.09 0.28  0.636 (0.092-4.390) 0.621 
PCB-167 0.20 0.13 0.41  0.27 0.12 0.40  1.640 (0.319-8.390) 0.573 
PCB-189 0.28 0.16 0.47  0.26 0.21 0.42  1.140 (0.217-5.930) 0.893 
∑non-ortho 0.65 0.48 1.42  0.34 0.27 0.57  0.041 (0.008-0.192) 0.017 
∑mono-ortho 4.92 3.59 7.64  3.39 2.16 5.19  0.073 (0.008-0.674) 0.045 
∑DL-PCBs 5.66 4.27 9.00  3.77 2.41 5.56  0.046 (0.004-0.431) 0.028 












Discussion  300 
When applying modified Poisson regression models, inverse significant associations after 301 
adjustment for confounders were found between paternal serum PCBs and clinical IVF outcomes. 302 
We detected associations between higher serum concentrations of PCBs 126 and 114 and reduced 303 
likelihood of embryo implantation. Interestingly, higher levels of non-ortho PCB-77 were associated 304 
with lower likelihood of clinical pregnancy and live birth. We also detected significantly lower 305 
probabilities of live birth among couples whose male partners presented higher serum 306 
concentrations of PCBs 105 and 118, as well as ∑non-ortho PCBs, ∑mono-ortho PCBs and 307 
∑DL-PCBs.  308 
The mean of total sum of DL-PCBs (∑DL-PCBs) obtained for the patients in our study was 309 
5.80 ng/g lipid (see Table 3). Comparing with previous studies carried out in general population not 310 
directly exposed to recognized emission sources, the level found is lower than the level in serum 311 
from the general population of Korea (10.30 ng/g lipid) (Park et al., 2009), and in the same order of 312 
the mean concentration found in serum from the general Chinese population (3.48 and 2.82 ng/g 313 
lipid, in 2011 and 2017 respectively) (Lin et al., 2018). 314 
Several authors have studied the DL-PCBs in blood serum samples from populations living in 315 
industrial areas or near urban waste treatment or incineration plants. Park et al. (2009) found a total 316 
DL-PCB level of 22.45 ng/g lipid in the blood from people living near a municipal solid waste 317 
incinerator in Korea. Zubero et al. (2017), found a total DL-PCB concentrations value of 7.41 ng/g 318 
lipid in serum samples from residents living near a municipal waste incinerator in Bilbao, Spain 319 
(Zubero et al., 2017). The values obtained for the male patients in our study are lower than those 320 
presented by these studies. 321 
We also contrasted our DL-PCB levels with the results from the concentrations reported in the U.S 322 
National Health and Nutrition Examination Survey (NHANES) for the period 2005-2016 (CDC, 323 











levels in US non-hispanic white males aged 40-59, with values in the range of 1.7 to 19.9 pg/g 325 
lipid (CDC, 2021). Nevertheless, the median values of each mono-ortho PCB were lower in serum 326 
of males of our study compared with the NHANES data, with the exception of PCB-123 for which 327 
the U.S Survey does not report a value because the proportion of results below limit of detection 328 
was too high to provide a valid result. 329 
In agreement with our data, several animal studies have reported a significant decrease in IVF 330 
success rates at low and environmental level doses of mixtures of PCBs (Campagna et al., 2002; 331 
Kholkute et al., 1994). Moreover, epidemiological researches, which have evaluated the long-term 332 
health consequences of exposure to TCDD among Vietnam War veterans and their offspring (Ngo 333 
et al., 2006, 2010), concluded that clear evidence exists for an association between dioxin exposure 334 
and human congenital disorders. Instead, studies on the effects of occupational exposure to TCDD 335 
indicate that the increases in the risk of spontaneous abortion (Schnorr et al., 2001), low birth weight 336 
or preterm delivery (Lawson et al., 2004) may not be related to paternal dioxin level.  337 
More recently, the Longitudinal Investigation of Fertility and the Environment (LIFE) Study 338 
reported male serum concentration of 36 PCBs (Buck Louis et al., 2013). Comparing these results 339 
to our findings remains difficult, since the LIFE Study analyzed the relationship between PCBs and 340 
couple fecundity measured by TTP. For instance, they found that serum concentrations of DL-PCBs 341 
118, 156, 157, and 167 in the male partners were inversely associated with couples’ fecundity. 342 
Interestingly, PCBs in male partners were more often associated with decreased fecundity than their 343 
female partners. Increased TTP reflects unobserved intermediate and clinical endpoints such as 344 
failed fertilization, altered embryo development, or implantation failure. Even though outcomes 345 
following a single IVF cycle were measured in the present study and not TTP, our findings point in 346 
the same direction as the decrease of fecundity reported in the LIFE study.  347 
These findings underscore the critical role of paternal exposure to environmental chemicals in 348 










disrupting activities of the environmental chemicals (Sharpe and Irvine, 2004). DL-PCBs are often 350 
regarded as antiestrogenic due to their ability to act through AhR (Plíšková et al., 2005). In this 351 
context, we previously found that mono-ortho PCB-189 was negatively correlated with male factors 352 
such as sperm motility, viability, and sperm morphology (Paul et al., 2017).  353 
The mechanism by which paternal exposure before conception may affect the development of the 354 
embryo is still unclear. Cumulative evidence suggests that in addition to genome sperm, various 355 
epigenetic factors such as DNA methylation, histone modifications and spermatozoal RNAs 356 
(Carrell, 2008; Soubry et al., 2014) may play an essential role in successful fertilization and early 357 
development of the embryo (Zajitschek et al., 2014). Additionally, recent data demonstrate that male 358 
dioxin exposure during the preconception period induces epigenetic modifications in male 359 
gametogenesis and abnormal development of the offspring (Estill and Krawetz, 2016; Pilsner et al., 360 
2017, 2018), resulting in reduced implantation rates and pregnancy outcomes. Future studies about 361 
the influence of preconception paternal exposure to dioxin-like compounds and epigenetic changes 362 
should be considered. 363 
With regard to the Spearman correlation analysis (see Table S2), it revealed that PCB-77 was highly 364 
intercorrelated with ∑non-ortho PCBs. We also observed that PCB-118, ∑non-ortho PCBs, ∑mono-365 
ortho PCBs and ∑DL-PCBs showed a very high correlation with PCB-105. PCB-114 showed a 366 
weak correlation, but still significant, with PCB-126, one of the most toxic congeners (Bhavsar et 367 
al., 2008). PCB-118 was highly correlated with ∑mono-ortho PCBs and ∑DL-PCBs. Besides, the 368 
highly toxic non-ortho PCBs 126 and 169 were strongly correlated. 369 
The high degree of correlation observed with the highly chlorinated PCBs 118, 156 and 105 is of 370 
special interest because they were found to be the most abundant in serum in the studied group. 371 
Former studies have reported these highly chlorinated congeners as markers for occupational 372 











suggest that a possible source of exposure to DL-PCBs in our study group might be through diet 374 
and/or occupational exposure. 375 
Due to the number of IVF couples analyzed, our results should be considered preliminary and 376 
examined in a larger cohort. For example, we had limited power to assess important modifying 377 
clinical factors such as the stimulation protocol used and the fertilization procedure. Besides, despite 378 
experimental and epidemiologic evidence of an association between diminished fecundity and 379 
exposure in females, our cohort was limited to male partners. Previous studies examining the 380 
relationship between maternal exposure to PCBs and IVF outcomes have demonstrated adverse 381 
outcomes, including oocyte maturity, oocytes fertilization, embryo quality and implantation failure. 382 
One such study (Mahalingaiah et al., 2010) was carried out on a prospective cohort study of 766 383 
women (who underwent 827 IVF cycles). The study assessed the association between serum levels 384 
of each congener or group of them (PCBs grouped by biological activity and total of PCBs) with 385 
implantation failure, chemical pregnancy, and spontaneous abortion. The researchers found a 386 
significant trend for serum levels of total PCBs and the odds of implantation failure. Nonetheless, 387 
no association was observed for other congeners or congener groupings with different IVF outcomes 388 
(Mahalingaiah et al., 2010). Another investigation reported higher serum levels of PCB-153 (46.2 389 
ng/g lipid) and the sum of all measured PCB congeners (∑PCBs) associated with significantly 390 
elevated dose-dependent odds of failed implantation among IVF patients in Boston, MA (Meeker 391 
et al., 2011). 392 
Bloom et al. (2017) reported associations between individual ovarian follicular fluid (FF) PCBs and 393 
IVF endpoints among women undergoing infertility treatment. The authors found a stronger 394 
association between FF PCB-105 levels and lower oocyte fertilization. Moreover, FF levels of PCBs 395 
87, 149, the sum of two PCB congeners with anti-estrogenic activity (PCBs 105 and 118), and total 396 
PCBs were associated with poorer embryo quality. Besides, there was a statistically significant 397 










(estrogenic PCBs and total PCBs). In Bloom’s study (2017), reduction of odds of live birth was 399 
associated with levels of individual PCBs 66, 74, 101 and PCBs with estrogenic activity. 400 
Unfortunately, the present study did not evaluate the effect of preconception exposure to PCBs in 401 
female partners, raising the possibility that including maternal data could change results for IVF 402 
outcomes. Therefore, we propose that future studies should include both maternal and paternal 403 
factors. Another limitation is that we selected only men attending the fertility clinic; therefore, our 404 
results should be applied only to that type of population.  405 
Despite the limited number of IVF couples analyzed, our findings indicate a negative relationship 406 
between paternal DL-PCB exposure and early pregnancy outcomes. In addition, we were able to 407 
analyze inter-correlations among individual PCB congeners, which is relevant to tracking possible 408 
routes of exposure and may be relevant to designing appropriate measures in order to reduce the 409 
impact of PCB exposure on IVF outcomes. It would be interesting to carry out future studies in 410 
order to examine relationships between serum DL-PCBs and other persistent organic pollutants such 411 
as non-DL-PCBs, PBDEs and organochlorine pesticides, which can also impact IVF (Buck Louis 412 
et al., 2013; Ingle et al., 2020). We were also able to determine individual congeners of DL-PCBs 413 
as potential predictors of IVF outcomes, which deserves further attention. These findings might 414 
provide a better understanding of the effects of paternal preconception exposure to DL-PCBs on 415 
developmental toxicity.  416 
Our findings suggest significant associations between low environmental levels of serum DL-PCBs 417 
in male partners of subfertile couples and pregnancy outcomes of IVF such as implantation, clinical 418 
pregnancy and live births. Further studies in larger population sizes with control of male and female 419 
confounders as well as technical factors related with assisted reproductive technologies are needed 420 
to confirm these results. Physicians should counsel both partners to reduce environmental exposure 421 
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